Duties of the Parties. JHU is not a commercial organization. It is an institute of research and education. Therefore, JHU has no ability to evaluate the commercial potential of any PATENT RIGHTS or LICENSED PRODUCT or other license or rights granted in this Agreement. It is therefore incumbent upon Company to evaluate the rights and products in question, to examine the materials and information provided by JHU, and to determine for itself the validity of any PATENT RIGHTS, its freedom to operate, and the value of any LICENSED PRODUCTS or SERVICES or other rights granted.
Duties of the Parties. 2.1. Tour Operator is obliged to:
Duties of the Parties. The roles and responsibilities of each Party are defined below:
Duties of the Parties. JHU is not a commercial organization. It is an institute of research and education. Therefore, JHU has no ability to evaluate the commercial potential of any PATENT RIGHTS or LICENSED PRODUCT or other license or rights granted in this Agreement. It is therefore incumbent upon Company to evaluate the rights and products in question, to examine the materials and information provided by JHU, and to determine for itself the validity of any PATENT RIGHTS, its freedom to operate, and the value of any LICENSED PRODUCTS or SERVICES or other rights granted. [***] Indicates portions of this exhibit that have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.
Duties of the Parties. The contracting parties are bound to fully implement all clauses of this Agreement in its own terms, as well as those of the PROTOCOL. Each party shall comply with their respective obligations as per the legislation indicated in Clause THREE. Each party’s obligations, duties and functions under RD 1090/2015 are deemed binding content of the present Agreement, and consequently any violation thereof shall be considered as non-compliance of the Agreement. The Parties are committed also to: Collaborating in the CLINICAL TRIAL follow-up visits conducted by: (i) the CREC, (ii) the monitors and auditors acting on behalf of the SPONSOR, and (iii) the competent authorities when conducting inspection interventions. There shall be at least a one week notice prior to these visits (unless the Parties agree otherwise). Technical and organizational steps will be taken during these follow-up, monitoring and audit visits to ensure full compliance with any applicable personal data protection statute. The PRINCIPAL INVESTIGATOR, the SPONSOR, the monitors and the auditors shall comply with both the HOSPITAL and the FOUNDATION internal rules as shall be notified by them, and with the instructions from the monitoring CREC about the execution of the CLINICAL TRIAL. Not entering into any agreements or commitments related to the implementation of the CLINICAL TRIAL that might result in exceptions or contradictions with its content. Therefore, each Party states that, at this date, none of them is a party in any agreement or pact that might contradict its content. In particular, by virtue of this Clause, the Parties agree that they shall in no event compromise or pay any compensation whatsoever other than those provided for in the Agreement, without prejudice to the expenses incurred for the attendance to/celebration of the meetings required to organize and supervise the execution of the STUDY and the meetings designed to analyze or make the STUDY’s results public (presentations or scientific publications). In addition to the obligations stated in the applicable norms, the SPONSOR shall provide constant support to the PRINCIPAL INVESTIGATOR and shall provide him/her and the CREC with any new information related to the drug under research that may be relevant. It is the FOUNDATION’s responsibility to manage the financial aspect of this CLINICAL TRIAL. To such affect, the FOUNDATION shall receive any payments made by the SPONSOR/CRO and shall distribute them according to the provision...
Duties of the Parties. LICENSOR is an institute of research and education and not a commercial organization. Therefore, LICENSOR has no ability to evaluate the commercial potential of any PATENT RIGHTS, LICENSED PRODUCT or LICENSED SERVICES or other license or rights granted in this AGREEMENT. It is therefore incumbent upon COMPANY to evaluate the rights, products and services in question, to examine the materials and information provided by LICENSOR and to determine for itself the validity of any PATENT RIGHTS, its freedom to operate, and the value of any LICENSED PRODUCTS or LICENSED SERVICES or other rights granted.
Duties of the Parties. The Parties shall facilitate the work of the arbitral tribunal and, in particular, in accordance with their law and using all means at their disposal, shall:
Duties of the Parties. 3.1 Promptly after the EFFECTIVE DATE, and thereafter at least once every calendar year, the RESEARCHERS shall provide SENETEK with a complete listing and description of all COMPOUNDS developed, in licensed or otherwise acquired by the RESEARCHERS, together with all chemical and biological information in their possession with respect to such COMPOUNDS and specifying those COMPOUNDS, if any, which are covered by RESEARCHERS’ PATENTS.
Duties of the Parties. 39.01 The Employing Authority acknowledges its duty to accommodate employees with disabilities in the manner and to the extent required by the Xxxxxx Xxxxxx Island Human Rights Act. The Employing Authority further agrees to continue its practice of accommodating workspaces to the needs of employees with disabilities.
Duties of the Parties. 2.1.The parties undertake to collaborate and keep each other informed concerning the Study in order to ensure its success.
